单药紫杉醇治疗晚期头颈部鳞状细胞癌 - Suppr

Suppr

超能文献

Single agent paclitaxel in advanced squamous cell head and neck carcinoma.

作者信息

Gebbia V, Testa A, Cannata G, Gebbia N

出版信息

Eur J Cancer. 1996 May;32A(5):901-2. doi: 10.1016/0959-8049(96)00002-0.

DOI:10.1016/0959-8049(96)00002-0

PMID:9081377

Abstract

摘要

相似文献

Single agent paclitaxel in advanced squamous cell head and neck carcinoma.

Eur J Cancer. 1996 May;32A(5):901-2. doi: 10.1016/0959-8049(96)00002-0.

Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390).

Cancer. 1998 Jun 1;82(11):2270-4.

Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck.

Cancer. 2000 Dec 15;89(12):2587-96. doi: 10.1002/1097-0142(20001215)89:12<2587::aid-cncr11>3.0.co;2-r.

A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma.

Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-51-S19-56.

Nanoparticle albumin-bound paclitaxel can be useful agent to advanced primary mucinous carcinoma of the skin.

J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2271-3. doi: 10.1111/jdv.12574. Epub 2014 Jun 9.

Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.

Cancer Res. 1996 Nov 15;56(22):5198-204.

2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.

Clin Cancer Res. 2004 Dec 15;10(24):8665-73. doi: 10.1158/1078-0432.CCR-04-1393.

Paclitaxel in simultaneous radiochemotherapy of head and neck cancer: preclinical and clinical results.

Semin Oncol. 1997 Feb;24(1 Suppl 2):S2-72-S2-77.

[Preclinical and clinical results in the simultaneous radiochemotherapy of head and neck tumors with Paclitaxel].

Strahlenther Onkol. 1996 May;172 Suppl 1:15-20.

Docetaxel said to be highly effective and well tolerated in advanced head and neck cancer.

Oncology (Williston Park). 1996 Mar;10(3):422.

引用本文的文献

Systemic therapy in head and neck cancer: changing paradigm.

Indian J Surg Oncol. 2013 Mar;4(1):19-26. doi: 10.1007/s13193-012-0197-4. Epub 2012 Dec 1.

Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell.

Int J Clin Exp Pathol. 2013 Nov 15;6(12):2745-56. eCollection 2013.

Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329.

Head Neck. 2014 Dec;36(12):1712-7. doi: 10.1002/hed.23522. Epub 2014 Jan 29.

Chemoradiation in Advanced Head and Neck Cancers: A Comparison of two Radiosensitizers, Paclitaxel and Cisplatin.

Indian J Otolaryngol Head Neck Surg. 2011 Jul;63(3):229-36. doi: 10.1007/s12070-011-0263-1. Epub 2011 May 7.

A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck.

Br J Cancer. 1999 Oct;81(3):457-62. doi: 10.1038/sj.bjc.6690715.

The taxoids. Comparative clinical pharmacology and therapeutic potential.

Drugs. 1998 Jan;55(1):5-30. doi: 10.2165/00003495-199855010-00002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验